v3.25.2
CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Preferred Stock
Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Gain (Loss)
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Balance, beginning (in shares) at Dec. 31, 2023   61 44,677          
Balance, beginning at Dec. 31, 2023 $ 69,739   $ 4 $ 409,343 $ (793) $ (67) $ (339,541) $ 793
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock-based compensation 1,124     1,124        
Issuance of common stock upon exercise of stock options (in shares)     33          
Issuance of common stock upon exercise of stock options 107     107        
Other comprehensive loss (65)         (65)    
Net loss (10,011)           (10,011)  
Balance, ending (in shares) at Mar. 31, 2024   61 44,710          
Balance, ending at Mar. 31, 2024 $ 60,894   $ 4 409,781   (132) (348,759)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Accounting Standards Update [Extensible Enumeration] us-gaap:AccountingStandardsUpdate202006Member              
Balance, beginning (in shares) at Dec. 31, 2023   61 44,677          
Balance, beginning at Dec. 31, 2023 $ 69,739   $ 4 409,343 $ (793) (67) (339,541) $ 793
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (21,789)              
Balance, ending (in shares) at Jun. 30, 2024   61 45,602          
Balance, ending at Jun. 30, 2024 52,388   $ 5 413,017   (97) (360,537)  
Balance, beginning (in shares) at Mar. 31, 2024   61 44,710          
Balance, beginning at Mar. 31, 2024 60,894   $ 4 409,781   (132) (348,759)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock, net of expenses (in shares) [1]     792          
Issuance of common stock, net of expenses [1] 1,805   $ 1 1,804        
Stock-based compensation 1,179     1,179        
Issuance of common stock upon exercise of stock options (in shares)     100          
Issuance of common stock upon exercise of stock options 253     253        
Other comprehensive loss 35         35    
Net loss (11,778)           (11,778)  
Balance, ending (in shares) at Jun. 30, 2024   61 45,602          
Balance, ending at Jun. 30, 2024 52,388   $ 5 413,017   (97) (360,537)  
Balance, beginning (in shares) at Dec. 31, 2024   61 66,524          
Balance, beginning at Dec. 31, 2024 82,949   $ 7 467,087   34 (384,179)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock-based compensation 1,365     1,365        
Issuance of common stock upon exercise of stock options (in shares)     2          
Issuance of common stock upon exercise of stock options 3     3        
Other comprehensive loss (7)         (7)    
Net loss (13,434)           (13,434)  
Balance, ending (in shares) at Mar. 31, 2025   61 66,526          
Balance, ending at Mar. 31, 2025 70,876   $ 7 468,455   27 (397,613)  
Balance, beginning (in shares) at Dec. 31, 2024   61 66,524          
Balance, beginning at Dec. 31, 2024 82,949   $ 7 467,087   34 (384,179)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (27,377)              
Balance, ending (in shares) at Jun. 30, 2025   61 66,526          
Balance, ending at Jun. 30, 2025 58,606   $ 7 470,138   17 (411,556)  
Balance, beginning (in shares) at Mar. 31, 2025   61 66,526          
Balance, beginning at Mar. 31, 2025 70,876   $ 7 468,455   27 (397,613)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock-based compensation 1,683     1,683        
Other comprehensive loss (10)         (10)    
Net loss (13,943)           (13,943)  
Balance, ending (in shares) at Jun. 30, 2025   61 66,526          
Balance, ending at Jun. 30, 2025 $ 58,606   $ 7 $ 470,138   $ 17 $ (411,556)  
[1]

(1) Net of expenses of $197,000.